Cargando…

Infliximab in the Treatment of Crohn Disease and Type 1 Diabetes

Detalles Bibliográficos
Autores principales: Timper, Katharina, Hruz, Petr, Beglinger, Christoph, Donath, Marc Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687309/
https://www.ncbi.nlm.nih.gov/pubmed/23801815
http://dx.doi.org/10.2337/dc13-0199
_version_ 1782273903016542208
author Timper, Katharina
Hruz, Petr
Beglinger, Christoph
Donath, Marc Y.
author_facet Timper, Katharina
Hruz, Petr
Beglinger, Christoph
Donath, Marc Y.
author_sort Timper, Katharina
collection PubMed
description
format Online
Article
Text
id pubmed-3687309
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-36873092014-07-01 Infliximab in the Treatment of Crohn Disease and Type 1 Diabetes Timper, Katharina Hruz, Petr Beglinger, Christoph Donath, Marc Y. Diabetes Care Online Letters: Observations American Diabetes Association 2013-07 2013-06-12 /pmc/articles/PMC3687309/ /pubmed/23801815 http://dx.doi.org/10.2337/dc13-0199 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Online Letters: Observations
Timper, Katharina
Hruz, Petr
Beglinger, Christoph
Donath, Marc Y.
Infliximab in the Treatment of Crohn Disease and Type 1 Diabetes
title Infliximab in the Treatment of Crohn Disease and Type 1 Diabetes
title_full Infliximab in the Treatment of Crohn Disease and Type 1 Diabetes
title_fullStr Infliximab in the Treatment of Crohn Disease and Type 1 Diabetes
title_full_unstemmed Infliximab in the Treatment of Crohn Disease and Type 1 Diabetes
title_short Infliximab in the Treatment of Crohn Disease and Type 1 Diabetes
title_sort infliximab in the treatment of crohn disease and type 1 diabetes
topic Online Letters: Observations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687309/
https://www.ncbi.nlm.nih.gov/pubmed/23801815
http://dx.doi.org/10.2337/dc13-0199
work_keys_str_mv AT timperkatharina infliximabinthetreatmentofcrohndiseaseandtype1diabetes
AT hruzpetr infliximabinthetreatmentofcrohndiseaseandtype1diabetes
AT beglingerchristoph infliximabinthetreatmentofcrohndiseaseandtype1diabetes
AT donathmarcy infliximabinthetreatmentofcrohndiseaseandtype1diabetes